Chronic Obstructive Pulmonary Disease (COPD) and emphysema are debilitating conditions that can make even simple tasks like walking or climbing stairs feel insurmountable. For many in the Texas ...

The US Food and Drug Administration (FDA) has approved the Zephyr Endobronchial Valve (Pulmonx Corp) to treat breathing difficulty associated with severe emphysema. "Treatment options are limited for ...

In late March, physicians at the University of Alabama at Birmingham carefully threaded a one-way valve the size of a black-eyed pea into the lower lobe of Dennis Bullock's left lung. Bullock, a ...

(Philadelphia, PA) - Temple University Hospital has become the first U.S. center to perform bronchoscopic lung volume reduction using implantation of the Zephyr® Endobronchial Valve (Zephyr® EBV®) to ...

REDWOOD CITY, Calif. & TOKYO--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announced today that the ...

Sept. 8, 2017--People with severe emphysema may breathe better after a minimally invasive procedure that places valves in the airways leading to diseased portions of their lungs, according to a ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation announced today that the French Health Ministry has granted national reimbursement for the Zephyr Endobronchial Valve, the first ...

The FDA today approved the Zephyr endobronchial valve for treating breathing difficulty associated with severe emphysema, according to a press release. “Treatment options are limited for people with ...

Pulmonx ® Corp. announced today that the U.S. Food and Drug Administration (FDA) has approved the Zephyr ® Endobronchial Valve System for treating severe emphysema patients. The Zephyr Valve is the ...

CHILLICOTHE— A new, minimally invasive procedure now being offered by Adena Health System for patients suffering from emphysema and COPD. “We’ve actually been talking about doing this type of ...

Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease Breathe Easier and Have a Better Quality of Life Over 600,000 Japanese patients suffer from ...